advanced medical technologies http://mediligence.com/blog insights, perspectives and inside data from the founder of MMD Thu, 20 Nov 2008 18:25:18 +0000 http://wordpress.org/?v=2.6.3 en Ablation and Other Medtech Developments: How to Do Things Differently, Sometimes Better http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/459804588/ http://mediligence.com/blog/2008/11/20/ablation-medtech-developments/#comments Thu, 20 Nov 2008 17:37:21 +0000 P. Driscoll http://mediligence.com/blog/?p=665  [Insight:  One of the more fascinating aspects of medical technology development is the penchant in the industry for finding different ways to accomplish traditional tasks in medical and surgical care.  While certainly some technologies can be oversold for their putative clinical benefits --- driving up healthcare costs and giving the industry a bad rap --- some medtech advances indeed provide clinically better outcomes that few can legitimately argue, IMHO, as not being cost effective.  These include major technology paradigm shifts like laparoscopic surgery.  Another area that has shown a progressive set of changes to medical and, especially, surgical care, has been ablation technologies, the use of energy-based and other technologies to accomplish the dissection of tissue, the destruction of cancerous and other lesions and other functional alternation of tissue (e.g., in arrhythmia ablation) that was in most cases previously accomplished by, for the most part, a scalpel only (OK, a little simplified, but you get the idea).  These ablation technologies now represent a pretty strong market or collection of market segments that are changing the way surgeons manipulate tissue.  Below are some highlights of how the market breaks down by different modality.  We also present some of the recent M&A activity in this industry.  For additional details on ablation technologies, see the tag or category of  "ablation" (or any of the separate modalities) in this blog. - Patrick Driscoll, Founder, MedMarket Diligence]

The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue. 

Global Ablation and Other Energy-Based Therapies 
Market Share and Compound Annual Growth Rate by Modality

 

Energy Modality
% Total Market
CAGR
2003-2013
Electrical
42%
12%
Radiation
24%
7%
Light
10%
11%
RadioFrequency
 9%
18%
Ultrasonic
 7.5%
16%
Cryogenic
 5%
18%
Thermal
 1.25%
18%
Microwave
 0.75%
22%
Hydromechanical
 0.5%
12%
 Total
100%
11%

Source:  MedMarket Diligence report #A125, "Worldwide Ablation Technologies 

The field of energy-based companies is well populated, partly because there are several different categories of energy application in clincial medicine, and because companies tend to be focused on single or tightly-focused energy applications. Thus there are companies specialising in cryoablation, thermal ablation, electrosurgery, brachytherapy and so on. Many companies have entered this field offering a new technology in one particular form of energy application.

A growing tendency in recent years has been the acquisition by larger, multifunctional medical device companies of smaller and often newer energy-based companies, as a means of adding a new technology to their portfolio. The past five years have seen many mergers and acquisitions of this kind involving energy-based companies. Exhibit 4-1 shows some examples of M&A activity from the past three years. 

M&A Activity Among Energy-based Companies
 
Acquirer
Target
Year
Technology
Cytyc
Proxima Therapeutics
2005
Radiation Therapy
Angiodynamics
RITA
2007
RFA
Hologic
Cytyc
2007
Endometrial ablation
St Jude
EP Medical Systems
2008
Cardiac electrophysiology
Boston Scientific
Guidant
2006
Pacemakers, defibrillators, etc
Olympus
Gyrus
2007
Radiofrequency
HealthTronics
Advanced Medical
Partners
2008
Cryotherapy
American Medical Systems
Laserscope
2006
Laser therapy
Galil Medical
Oncura
2006
Cryoablation
Guidant
AFx
2004
Microwave
Warburg Pincus
Bausch & Lomb
2007
Excimer laser
Valleylab (Covidien)
Vivant
2005
Microwave
Olympus
Celon
2004
Radiofrequency thermotherapy
TheraGenics
Galt Medical
2006
 
Gyrus
ACMI
2005
Thermal therapy
Guidant
AFx
2004
Microwave
Boston Scientific
Cryocor
2008
Cryoablation
HealthTronics
Endocare
2008 (pending)
Cryoablation

Source:  MedMarket Diligence report #A125, "Worldwide Ablation Technologies 

]]> http://mediligence.com/blog/2008/11/20/ablation-medtech-developments/feed/ http://mediligence.com/blog/2008/11/20/ablation-medtech-developments/ European Ophthalmic Pharmaceuticals Market, by Segment, 2004-2012 http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/456481648/ http://mediligence.com/blog/2008/11/17/european-ophthalmic-pharma/#comments Mon, 17 Nov 2008 22:07:00 +0000 P. Driscoll http://mediligence.com/blog/?p=653 (Excerpt from Report #G125, Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007.)

Although there is a broad spectrum of medical technology innovations taking place in the ophthalmology sector, pharmaceuticals will continue to be a critical component of both elective and emergency ocular interventions. As a result, the dominant players in the pharmaceutical sector will realize strong growth, particularly in the areas of Dry Eye management (as a result of complications following refractive surgery), Glaucoma medications and treatments for wet AMD.

In addition, the generic drug sector will experience strong growth, particularly as expensive therapies for AMD reach the market and usurp scarce financial resources of markets with socialized healthcare systems.

Below is a forecast of the European ophthalmic pharmaceuticals market by segment.

The market in Europe for ophthalmic pharmaceuticals is dominated by Alcon, with Pfizer showing a distant second. 

The report #G125 on the worldwide ophthalmic products market is available for purchase and immediate download at link.

 

]]> http://mediligence.com/blog/2008/11/17/european-ophthalmic-pharma/feed/ http://mediligence.com/blog/2008/11/17/european-ophthalmic-pharma/ Surgical sealants, glues, wound closure, anti-adhesion, worldwide http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/456304656/ http://mediligence.com/blog/2008/11/17/sealants-glues-antiadhesion-report/#comments Mon, 17 Nov 2008 19:12:02 +0000 P. Driscoll http://mediligence.com/blog/?p=650 [Publisher's note:  The report #S175 described below is the most recent in a highly regarding industry series tracking this huge med/surg market, with its implication for devices, biologics, biomaterials and other products across a wide range of clinical application sectors. The report is pending publication in early December 2008.]

Report #S175, entitled, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013," (see link) details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

The report is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products and medical adhesives. The report provides a worldwide current and annual forecast to 2013 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade.

The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World. The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies. The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

The report offers key benefits: 

  • Worldwide scope enables comprehensive opportunity assessment
  • Geographic segmentation, based on ground-level analysis, reveals local potential
  • Detailed company profiles provide real awareness of competitive landscape
  • Forecasts to 2013 reveal insights of relative future market impact
  • Competitor market shares by segment give hard, actionable data

  The report is available for purchase on an advance discount at link.

]]> http://mediligence.com/blog/2008/11/17/sealants-glues-antiadhesion-report/feed/ http://mediligence.com/blog/2008/11/17/sealants-glues-antiadhesion-report/ Tissue ablation: microwave, thermal, hydro and cryo on the rise http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/456264532/ http://mediligence.com/blog/2008/11/17/tissue-ablation-types-growth/#comments Mon, 17 Nov 2008 18:21:08 +0000 P. Driscoll http://mediligence.com/blog/?p=647 Ablation Worldwide Market, 2007 to 2017Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones.  These modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, radiofrequency (RF), light, radiation (radiosurgery, radiotherapy) and electrical.

At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to come from microwave, thermal, hydromechanical and cryotherapy, each of which will demonstrate compound growth rates in excess of 15% annually.

Excerpt from report #A125, “Ablation Technologies Worldwide Market,” (published September 2008).  See link.  Report #A125, “Ablation Technologies Worldwide”, may be purchased online.

 

 

]]> http://mediligence.com/blog/2008/11/17/tissue-ablation-types-growth/feed/ http://mediligence.com/blog/2008/11/17/tissue-ablation-types-growth/ India’s Growth Market in Ablation Technology http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/453490544/ http://mediligence.com/blog/2008/11/14/india-ablation-market/#comments Fri, 14 Nov 2008 23:53:31 +0000 P. Driscoll http://mediligence.com/blog/?p=643 The medical markets inthe Asia/Pacific region show enormous variations in size, due to differences in healthcare expenditure as well as the obvious differing population sizes. Although China and India have vastly greater populations than other countries in the region, it is the Japanese ablation market that takes the largest share of the global market, with an estimated 6.2%. This country’s medical market has been showing a modest (3%) annual growth after a period of stagnation.  However, in terms of absolute growth rate for sals of ablation technology products, India is the leader, edging out even China.

 

Source:  MedMarket Diligence Report #A125, "Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities."  Published September 2008.

 

This MedMarket Diligence report #A125, "Ablation Technologies Worldwide Market," is described in detail here. The report may be purchased for immediate download here.

 

]]> http://mediligence.com/blog/2008/11/14/india-ablation-market/feed/ http://mediligence.com/blog/2008/11/14/india-ablation-market/ Analysis pending on sealants, glues, wound closure, anti-adhesion http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/453292136/ http://mediligence.com/blog/2008/11/14/sealants-report-s175/#comments Fri, 14 Nov 2008 19:42:46 +0000 P. Driscoll http://mediligence.com/blog/?p=640 Below is a a report to be published (December 2008) from MedMarket Diligence on the worldwide surgical sealants, glues, wound closure and anti-adhesion market.  The report is described at this link.

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013

· 225 pages · 60 Exhibits · 79 Company Profiles · Report #S175 · Publishing December 2008

This report details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products and medical adhesives. The report provides a worldwide current and annual forecast to 2013 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World.

The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

 

(For more information, see link or contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)

]]> http://mediligence.com/blog/2008/11/14/sealants-report-s175/feed/ http://mediligence.com/blog/2008/11/14/sealants-report-s175/ Wound management: established and emerging products, technologies and markets worldwide http://feeds.feedburner.com/~r/AdvancedMedicalTechnologies/~3/453274645/ http://mediligence.com/blog/2008/11/14/worldwide-wound-management/#comments Fri, 14 Nov 2008 19:30:27 +0000 P. Driscoll http://mediligence.com/blog/?p=638 Below is a report from MedMarket Diligence on the worldwide wound management market.  The report is described in detail here.

Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World 

· 256 pages · 64 Exhibits · 69 Company Profiles · Report #S245 · Published Nov. 2007

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

(For more information, see link or contact Patrick Driscoll, patrick at mediligence dot com, or tel: 949-859-3401.)